Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background

Kidney Int. 2019 Dec;96(6):1303-1307. doi: 10.1016/j.kint.2019.07.010. Epub 2019 Aug 1.

Abstract

The Apolipoprotein L1 (APOL1) risk variants G1 and G2 are associated with high rates of kidney disease in African Americans in genetic studies. However, our understanding of APOL1 biology has lagged far behind. Here we report that engineering G1 and G2 mutations on unnatural haplotype backgrounds instead of on the specific G1 and G2 haplotype backgrounds that occur in nature profoundly alters APOL1-mediated cytotoxicity in experimental systems. Thus, in addition to helping resolve some important controversies in the APOL1 field, our demonstration of the critical influence of haplotype background may apply more generally to the study of other genetic variants that cause or predispose to human disease.

Keywords: APOL1; chronic kidney disease; focal segmental glomerulosclerosis; haplotype; trypanosome.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural